Qube Research & Technologies (QRT)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359K Sell
1,600
-300
-16% -$74.8K ﹤0.01% 2830
2025
Q4
$458K Sell
1,900
-1,300
-41% -$332K ﹤0.01% 2826
2025
Q3
$876K Sell
3,200
-6,800
-68% -$1.86M ﹤0.01% 2571
2025
Q2
$2.58M Buy
10,000
+9,500
+1,900% +$2.27M ﹤0.01% 2077
2025
Q1
$112K Sell
500
-1,800
-78% -$420K ﹤0.01% 2987
2024
Q4
$526K Buy
2,300
+2,100
+1,050% +$506K ﹤0.01% 2448
2024
Q3
$48.8K Buy
+200
New +$44.7K ﹤0.01% 2867
2024
Q2
Sell
-500
Closed -$99K 4572
2024
Q1
$99K Buy
500
+300
+150% +$55K ﹤0.01% 3302
2023
Q4
$34.4K Buy
+200
New +$30.7K ﹤0.01% 3386

Other funds holding RMD

Qube Research & Technologies (QRT)'s RMD Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of ResMed (RMD) in Q4 2025, closing a stake of 142,863 shares — an estimated $36.5M sold.

Qube Research & Technologies (QRT) first reported a position in RMD in Q2 2018 and held it in 19 quarters. The position peaked at $82.6M in Q2 2023. 945 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 142,863 ResMed shares in Q4 2025, an estimated $36.5M.
  • Qube Research & Technologies (QRT) first reported a position in ResMed in Q2 2018 and held it in 19 quarters.
  • Qube Research & Technologies (QRT)'s ResMed position peaked at $82.6M in Q2 2023.
  • 945 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.